CSL has enrolled long COVID patients in a study examining the effectiveness of immunoglobulin therapy for treating postural orthostatic tachycardia syndrome (POTS). This new treatment approach aims to alleviate symptoms and improve quality of life for individuals struggling with POTS. The study is ongoing, with results expected to provide valuable insights into the potential benefits and limitations of this therapy.

Source: https://www.bloomberg.com/news/articles/2024-10-25/csl-enrolls-long-covid-patients-in-study-of-immunoglobulin-therapy-for-pots